New patent for Abbvie drug RESTASIS

Annual Drug Patent Expirations for RESTASIS Restasis is a drug marketed by Abbvie and is included in one NDA. It is available from four suppliers. There are ten patents protecting…

The post New patent for Abbvie drug RESTASIS appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog